Jane M. Raymond

2.1k total citations · 1 hit paper
15 papers, 779 citations indexed

About

Jane M. Raymond is a scholar working on Oncology, Hematology and Cancer Research. According to data from OpenAlex, Jane M. Raymond has authored 15 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Hematology and 3 papers in Cancer Research. Recurrent topics in Jane M. Raymond's work include Cancer Treatment and Pharmacology (3 papers), Platelet Disorders and Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Jane M. Raymond is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Platelet Disorders and Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Jane M. Raymond collaborates with scholars based in United States, Canada and United Kingdom. Jane M. Raymond's co-authors include Mohammed Moinuddin, Stephen W. Hardeman, Scott M. Soloway, Mark S. Soloway, David P. Hickey, Zella R. Zeigler, Jeffrey Gryn, Richard K. Shadduck, John Lister and D. Facklam and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Thrombosis and Haemostasis.

In The Last Decade

Jane M. Raymond

15 papers receiving 749 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

1988 525 citations Mark S. Soloway, Stephen W. Hardeman et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane M. Raymond United States	9	466	348	209	96	89	15	779
Hakan Harputluoğlu Türkiye	14	168 0.4×	364 1.0×	57 0.3×	127 1.3×	63 0.7×	49	728
M. Garbrecht Germany	9	152 0.3×	130 0.4×	229 1.1×	49 0.5×	40 0.4×	38	593
Prashanth Giridhar India	11	137 0.3×	191 0.5×	108 0.5×	50 0.5×	52 0.6×	43	507
Francine R. Dembitzer United States	12	269 0.6×	94 0.3×	83 0.4×	33 0.3×	82 0.9×	21	831
Keijiro Kiyoshima Japan	14	467 1.0×	151 0.4×	148 0.7×	27 0.3×	31 0.3×	41	850
Nasir Bakshi Saudi Arabia	13	155 0.3×	91 0.3×	55 0.3×	48 0.5×	117 1.3×	47	504
Vittorio Donato Italy	15	250 0.5×	156 0.4×	183 0.9×	49 0.5×	55 0.6×	56	657
Robert R. Carroll United States	10	184 0.4×	705 2.0×	100 0.5×	34 0.4×	104 1.2×	14	894
Katsuhiro Takano Japan	17	297 0.6×	176 0.5×	66 0.3×	99 1.0×	321 3.6×	28	1.1k
J F Botet United States	15	768 1.6×	575 1.7×	69 0.3×	113 1.2×	47 0.5×	23	1.4k

Countries citing papers authored by Jane M. Raymond

Since Specialization

Citations

This map shows the geographic impact of Jane M. Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane M. Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane M. Raymond more than expected).

Fields of papers citing papers by Jane M. Raymond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane M. Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane M. Raymond. The network helps show where Jane M. Raymond may publish in the future.

Co-authorship network of co-authors of Jane M. Raymond

This figure shows the co-authorship network connecting the top 25 collaborators of Jane M. Raymond. A scholar is included among the top collaborators of Jane M. Raymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane M. Raymond. Jane M. Raymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Raymond, Jane M., et al.. (2012). Metastatic renal cell cancer presenting as a breast mass.. PubMed. 10(2). 124–6. 4 indexed citations

Kontoyiannis, Dimitrios P., V. Ratanatharathorn, Jo‐Anne H. Young, et al.. (2008). Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis. Transplant Infectious Disease. 11(1). 89–93. 75 indexed citations

Hamm, John, John Wilson, Priya Rastogi, et al.. (2008). Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group. Clinical Breast Cancer. 8(3). 257–263. 8 indexed citations

Barton, Debra L., Charles L. Loprinzi, Philip J. Atherton, et al.. (2007). Phase II Evaluation of Desipramine for the Treatment of Hot Flashes. PubMed. 4(4). 219–224. 7 indexed citations

Jacobs, Samuel A., John Wilson, Janell Seeger, et al.. (2007). A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer. Investigational New Drugs. 25(6). 545–551. 17 indexed citations

Jacobs, Samuel A., J. A. Wilson, Janell Seeger, et al.. (2007). A phase II clinical trial of ZD1839 (gefitinib) in combination with docetaxel as first-line treatment in patients with advanced breast cancer. Journal of Clinical Oncology. 25(18_suppl). 1059–1059. 1 indexed citations

Raymond, Jane M., et al.. (2005). Cancer chemotherapy administered via hemodialysis fistulas. The Journal of Vascular Access. 6(4). 196–199. 1 indexed citations

Gryn, Jeffrey, Richard K. Shadduck, John Lister, Zella R. Zeigler, & Jane M. Raymond. (2002). Factors Affecting Purification of CD34 ⁺ Peripheral Blood Stem Cells Using the Baxter Isolex 300i. Journal of Hematotherapy & Stem Cell Research. 11(4). 719–730. 13 indexed citations

Gryn, Jeffrey, Zella R. Zeigler, Richard K. Shadduck, et al.. (2002). Treatment of myelodysplastic syndromes with 5-azacytidine. Leukemia Research. 26(10). 893–897. 40 indexed citations

10.

Zeigler, Zella R., John Lister, Jane M. Raymond, et al.. (1998). Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. American Journal of Hematology. 59(1). 9–14. 19 indexed citations

11.

Zeigler, Zella R., C. S. Rosenfeld, David Andrews, et al.. (1996). Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). American Journal of Hematology. 53(4). 213–220. 51 indexed citations

12.

Soloway, Mark S., Stephen W. Hardeman, David P. Hickey, et al.. (1988). Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 61(1). 195–202. 525 indexed citations breakdown →

13.

Raymond, Jane M. & Lawrence A. Loeb. (1983). Molecular Biology and Malignancy: Series Introduction Mechanisms of Neoplastic Transformation. Cancer Investigation. 1(2). 175–183. 5 indexed citations

14.

Zuck, Thomas F., et al.. (1972). A Rapid Simplified Prothrombin Assay. American Journal of Clinical Pathology. 57(3). 352–358. 2 indexed citations

15.

Raymond, Jane M., et al.. (1971). Platelet Adhesiveness in Symptomatic Women Taking Oral Contraceptives. Thrombosis and Haemostasis. 26(3). 426–430. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact